Developing specific outsourcing and operational strategies to meet the demands of your company’s resources and capabilities
OCT Southern California is back for the 4th year and in 2016 promises to be the must-attend event for clinical operations professionals from the region.
The 2016 agenda is dedicated to the challenges faced by small and virtual companies, with case study presentations from pharmaceutical giants, to provide a complete overview of the key challenges facing the clinical operations and outsourcing community.
With presentations focused on funding, contract negotiations, patient centricity and strategic partnerships, the event will provided a perfect platform for problem-solving, knowledge sharing and networking with the clinical community across the Southern California region.
Alongside the conference, the event boats a growing informal exhibition area, which provides an effective networking opportunity for sponsors to meet with different service providers of a variety of sizes and expertise.
OCT Southern California is back for 2016 and the agenda 4th annual event focuses on the challenges faced by the smaller companies in the region.
For companies in the Southern California region and beyond, funding is of course a top priority for the biotech and pharma community. Companies need to ensure that their trial appears attractive to investors as well as identifying which investment route their company should embark on for their trial.
Mergers and acquisitions are occurring all over the clinical landscape on both sides of the sponsor-vendor relationship, with 2015 being listed as an all time record year for pharma/biotech mergers and acquisitions.
Following on from a fantastic event in 2015, exhibition spaces are filling up fast. These exhibition stands offer companies a unique opportunity for companies to promote their products and services to senior level decision makers from the region.
Primary delegates for this event are those with responsibility for clinical operations, outsourcing, procurement and alliances in biotech and pharmaceutical companies in the Southern California region.